Targeted genome editing in acute lymphoblastic leukemia: a review
Abstract Background Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. Results We show how the recent availability of genome-editing tools such as CRISPR-Cas9 are an important me...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2018-07-01
|
| Saila: | BMC Biotechnology |
| Gaiak: | |
| Sarrera elektronikoa: | http://link.springer.com/article/10.1186/s12896-018-0455-9 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|